We understand that some patients may wish to access our unapproved investigational medicines through an expanded access program, sometimes referred to as compassionate use. Based on the current stage of development of each of our investigational medicines, we believe that participation in clinical trials is the most appropriate way to access our investigational medicines. Therefore, we do not currently offer an expanded access program.

We encourage all patients and physicians who are interested in accessing our investigational medicines to visit the clinicaltrials.gov website to learn more about our clinical trials.